Understanding that improvements in sanitation, farming practices, food handling  and other health practices are necessary to drive the elimination of many of the diseases we target, ODG also believes that improved chemotherapeutic treatment of these infections has the potential to significantly improve patient, family and community quality of life. Thus, we are passionate in our effort to take the clinical development of oxfendazole as far as it can go–hopefully to gain its registration for use against many currently poorly treated parasitic infections world wide.